Results 1 to 10 of about 46,198 (239)

Successful Topical Treatment of Hydroxyurea-Induced Ulcers Without Drug Discontinuation: A Case Report. [PDF]

open access: yesCase Rep Hematol
Hydroxyurea, an antineoplastic agent, is widely used to treat essential thrombocythemia and polycythemia vera. Although hydroxyurea‐induced skin ulcers are uncommon, they are a recognized long‐term adverse effect.
Wang Y, He M, Han B, Zhang Q, Ma R.
europepmc   +3 more sources

Beliefs about hydroxyurea in youth with sickle cell disease

open access: yesHematology/Oncology and Stem Cell Therapy, 2018
Background: Hydroxyurea reduces complications and improves health-related quality of life (HRQOL) in sickle cell disease (SCD) patients, however adherence remains suboptimal. Understanding patients’ views of hydroxyurea is critical to optimize adherence,
Alexis A. Thompson   +2 more
core   +2 more sources

Hydroxyurea-Induced Hypersensitivity Pneumonitis: A Case Report and Literature Review [PDF]

open access: yesCanadian Respiratory Journal, 2000
Hydroxyurea is a cytotoxic agent indicated in the treatment of a variety of malignant and nonmalignant conditions. Apart from dose-related bone marrow suppression, this antineoplastic agent is generally well tolerated.
Paul Hernandez   +2 more
core   +2 more sources

Widespread Natural Occurrence of Hydroxyurea in Animals. [PDF]

open access: yesPLoS ONE, 2015
Here we report the widespread natural occurrence of a known antibiotic and antineoplastic compound, hydroxyurea in animals from many taxonomic groups.
Jacob W Robinson   +8 more
core   +2 more sources

Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease

open access: yesGenetics and Molecular Biology, 2004
Hydroxyurea is commonly used in the treatment of myeloproliferative diseases and in patients with sickle cell disease (SCD). The use of this antineoplastic agent in patients with SCD is justified because of the drug's ability to increase fetal hemoglobin
Guimarães Adriana Costa   +6 more
core   +1 more source

Model-Informed Evaluation of Hydroxyurea Exposure During Lactation. [PDF]

open access: yesClin Pharmacol Ther
Hydroxyurea is a cornerstone therapy for sickle cell anemia; however, evidence guiding its use during lactation remains limited. This study aimed to develop a population pharmacokinetic (PK) model to characterize hydroxyurea disposition in maternal plasma and breast milk, and to quantify infant exposure under clinically relevant breastfeeding scenarios.
Hosawi A   +5 more
europepmc   +2 more sources

Effect of treatment with hydroxyurea on calcium homeostasis in β-thalassemia-major patients

open access: yesAl-Azhar Assiut Medical Journal, 2021
Background and aim Thalassemia is a chronic illness that has a range of serious clinical and psychological effects, it does not only affect the physical functioning of patients but also their emotional and social functioning and school functionings ...
Khaled H Hassan
doaj   +1 more source

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia

open access: yesScientific Reports, 2022
Hydroxyurea is an antimetabolite drug that induces fetal haemoglobin in sickle cell disease. However, its clinical usefulness in β-thalassaemia is unproven.
Nirmani Yasara   +11 more
doaj   +1 more source

Spermatogenesis in Mice exposed to Hydroxyurea: Protecitve effect of ntural apple cider vinegar [PDF]

open access: yesمجلة التربية والعلم, 2005
The effect of hydroxyurea at a close of 80mg/kg/day orally for (7) days on Spermatogenesis and the protective role of NACV (Natural apple cider vinegar) has been studied in mature male mice.
Aticka El-Nouri, Rafah Ayoub
doaj   +1 more source

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative

open access: yesFrontiers in Genetics, 2022
Sickle cell disease (SCD) is an inherited blood disorder that affects about 100,000 people in the U.S., primarily Blacks/African-Americans. A multitude of complications negatively impacts quality of life. Hydroxyurea has been FDA approved since 1998 as a
Marsha J. Treadwell   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy